These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 28506386)

  • 21. Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease.
    Vega GL; Grundy SM
    J Lipid Res; 1984 Jun; 25(6):580-92. PubMed ID: 6747462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.
    Winocour PH; Durrington PN; Bhatnagar D; Mbewu AD; Ishola M; Mackness M; Arrol S
    Diabetes Res Clin Pract; 1992 Dec; 18(3):173-84. PubMed ID: 1289018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
    Ballantyne CM; Olsson AG; Cook TJ; Mercuri MF; Pedersen TR; Kjekshus J
    Circulation; 2001 Dec; 104(25):3046-51. PubMed ID: 11748098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the correlation between non-high density lipoprotein cholesterol and coronary heart disease in elderly Chinese.
    Ke D; Chen Q; Wu Q; Li X; Wu Z; Li G; Deng W; Mo X
    Intern Med; 2011; 50(12):1279-85. PubMed ID: 21673462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
    Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG
    Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese.
    Chien KL; Hsu HC; Su TC; Chen MF; Lee YT; Hu FB
    J Lipid Res; 2007 Nov; 48(11):2499-505. PubMed ID: 17698856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography.
    Song Y; Yang Y; Zhang J; Wang Y; He W; Zhang X; Zhu J; Lu Z
    Lipids Health Dis; 2015 Nov; 14():150. PubMed ID: 26582246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study.
    Ren X; Wang X
    Curr Med Res Opin; 2023 Sep; 39(9):1175-1181. PubMed ID: 37560911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol.
    Björnson E; Adiels M; Gummesson A; Taskinen MR; Burgess S; Packard CJ; Borén J
    J Am Coll Cardiol; 2024 Oct; 84(14):1328-1338. PubMed ID: 39322327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discordance between apolipoprotein B or non-HDL-cholesterol and LDL-cholesterol in middle-aged and elderly Chinese patients predicts arterial stiffness.
    Qu G; Zhang Z; Zhu H
    Lipids Health Dis; 2021 Jul; 20(1):80. PubMed ID: 34325713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterol.
    Rubins HB; Schectman G; Wilt TJ; Iwane MK
    Arch Intern Med; 1992 Dec; 152(12):2412-6. PubMed ID: 1456850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL).
    Holme I; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
    Ann Med; 2008; 40(6):456-64. PubMed ID: 19160529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.
    Kastelein JJ; van der Steeg WA; Holme I; Gaffney M; Cater NB; Barter P; Deedwania P; Olsson AG; Boekholdt SM; Demicco DA; Szarek M; LaRosa JC; Pedersen TR; Grundy SM; ;
    Circulation; 2008 Jun; 117(23):3002-9. PubMed ID: 18519851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein ratios are better than conventional lipid parameters in predicting coronary heart disease in Chinese Han people.
    Zhu L; Lu Z; Zhu L; Ouyang X; Yang Y; He W; Feng Y; Yi F; Song Y
    Kardiol Pol; 2015; 73(10):931-8. PubMed ID: 25985729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare Protein-Truncating Variants in APOB, Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease.
    Peloso GM; Nomura A; Khera AV; Chaffin M; Won HH; Ardissino D; Danesh J; Schunkert H; Wilson JG; Samani N; Erdmann J; McPherson R; Watkins H; Saleheen D; McCarthy S; Teslovich TM; Leader JB; Lester Kirchner H; Marrugat J; Nohara A; Kawashiri MA; Tada H; Dewey FE; Carey DJ; Baras A; Kathiresan S
    Circ Genom Precis Med; 2019 May; 12(5):e002376. PubMed ID: 30939045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.
    Ruixing Y; Yiyang L; Meng L; Kela L; Xingjiang L; Lin Z; Wanying L; Jinzhen W; Dezhai Y; Weixiong L
    Lipids Health Dis; 2010 Aug; 9():86. PubMed ID: 20716347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
    Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
    Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
    Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
    JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men.
    Austin MA; Rodriguez BL; McKnight B; McNeely MJ; Edwards KL; Curb JD; Sharp DS
    Am J Cardiol; 2000 Aug; 86(4):412-6. PubMed ID: 10946034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.